Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PACS
PACS logo

PACS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
33.630
Open
32.890
VWAP
32.29
Vol
577.40K
Mkt Cap
4.98B
Low
31.570
Amount
18.64M
EV/EBITDA(TTM)
11.59
Total Shares
157.17M
EV
5.36B
EV/OCF(TTM)
13.26
P/S(TTM)
0.99
PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services.
Show More

Events Timeline

(ET)
2026-02-26
16:40:00
Company Reports Q4 Revenue of $1.36B
select
2026-02-26
16:40:00
PACS Sees 2026 Adjusted EBITDA of $555M-$575M
select
2026-01-20 (ET)
2026-01-20
17:50:00
Pacs Group Acquires Three Post-Acute Care Facilities with 230 Beds
select

News

Newsfilter
1.0
03-16Newsfilter
PACS Group to Present at Oppenheimer Healthcare Conference
  • Conference Details: PACS Group will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 17, 2026, from 12:40 to 1:10 p.m. Eastern Time, showcasing the company's operations and growth strategy.
  • Executive Participation: CEO and Chairman Jason Murray, along with Interim CFO Mark Hancock, will jointly present at the conference, sharing relevant information to enhance investor understanding of the company.
  • Live Webcast: The presentation will be available via live webcast, which will be archived approximately one hour after the event and accessible for 90 days, allowing investors who cannot attend live to obtain the information.
  • Company Overview: Founded in 2013, PACS Group is one of the largest post-acute healthcare companies in the U.S., with independent subsidiaries operating over 320 post-acute care facilities across 17 states, serving more than 31,700 patients daily.
moomoo
6.0
03-04moomoo
PACS GROUP INC: UBS Increases Price Target from $42 to $44
  • Company Announcement: PACSGROUP Inc. has raised its target price for shares.

  • New Target Price: The new target price is set at $44, an increase from the previous $42.

moomoo
4.0
03-04moomoo
PACS GROUP INC.: Oppenheimer Increases Price Target to $42, Up from $40
  • Price Increase Announcement: PACSGROUPE Inc. has raised its price target for Oppenheimer from $40 to $42.
  • Market Implications: This adjustment reflects a positive outlook on the company's performance and potential growth in the market.
seekingalpha
9.5
02-27seekingalpha
PACS Group Projects Strong 2026 Revenue Growth
  • Earnings Highlights: PACS Group reported a GAAP EPS of $1.22 for FY 2025, with revenue reaching $5.29 billion, reflecting a robust 29.3% year-over-year growth, underscoring the company's strong performance in the healthcare facilities sector.
  • 2026 Revenue Guidance: The company projects revenue for 2026 to be between $5.65 billion and $5.75 billion, indicating strong confidence in future growth and providing clear financial guidance for investors.
  • Adjusted EBITDA Outlook: PACS anticipates adjusted EBITDA in the range of $555 million to $575 million for 2026, highlighting the company's efforts in cost control and enhancing profitability.
  • Market Performance: PACS Group has emerged as the top-performing healthcare facilities stock year-to-date, further solidifying its leadership position in the industry.
seekingalpha
9.5
02-27seekingalpha
PACS Group Reports Record Q4 2025 Earnings and Growth Outlook
  • Record Performance: PACS Group reported Q4 2025 revenue of $1.36 billion, reflecting a 12% year-over-year increase, with net income of $59.8 million, showcasing the company's strong execution in integrating acquisitions and operational excellence, which is expected to drive future growth.
  • Quality Improvement: Currently, 73.4% of the 207 facilities are rated 4 or 5 stars by CMS, with the average star rating in mature facilities rising to 4.4, indicating significant progress in enhancing clinical quality and customer satisfaction, thereby strengthening market competitiveness.
  • Positive Outlook: PACS anticipates 2026 revenue between $5.65 billion and $5.75 billion, representing nearly 8% growth, with adjusted EBITDA projected to grow nearly 12%, reflecting the company's robust strategy for organic growth and disciplined capital allocation.
  • Ongoing Acquisition Activity: Management plans to acquire approximately 5 facilities per quarter in 2026, and despite facing rising industry pricing challenges, the company maintains a strong acquisition pipeline, demonstrating confidence in future expansion.
Newsfilter
9.5
02-25Newsfilter
PACS Group to Release FY 2025 Financial Results on February 26, 2026
  • Earnings Release Schedule: PACS Group plans to release its fiscal year and fourth quarter 2025 financial results after market close on February 26, 2026, which is expected to provide critical financial data and business performance insights to help investors assess the company's future growth potential.
  • Conference Call Announcement: Management will host a conference call on February 26, 2026, at 5:30 p.m. ET to discuss the financial results and related information, allowing investors to participate via webcast or by dialing in, thereby enhancing engagement with stakeholders.
  • Investor Information Channels: The company encourages investors to regularly monitor its press releases, SEC filings, and webcasts for potentially material updates, ensuring transparency and timely communication of important developments.
  • Company Background Overview: Founded in 2013, PACS Group is one of the largest post-acute healthcare platforms in the U.S., with independent subsidiaries operating over 320 post-acute care facilities across 17 states, serving more than 31,700 patients daily, highlighting its significant position and influence in the industry.
Wall Street analysts forecast PACS stock price to rise
5 Analyst Rating
Wall Street analysts forecast PACS stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
40.00
Averages
42.60
High
47.00
Current: 0.000
sliders
Low
40.00
Averages
42.60
High
47.00
UBS
NULL -> Buy
maintain
$42 -> $44
AI Analysis
2026-03-04
Reason
UBS
Price Target
$42 -> $44
AI Analysis
2026-03-04
maintain
NULL -> Buy
Reason
UBS raised the firm's price target on Pacs Group to $44 from $42 and keeps a Buy rating on the shares.
Oppenheimer
Oppenheimer
Outperform
maintain
$40 -> $42
2026-03-04
Reason
Oppenheimer
Oppenheimer
Price Target
$40 -> $42
2026-03-04
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on Pacs Group to $42 from $40 and keeps an Outperform rating on the shares following the company's Q4 results and 10-K. Following its internal investigation and related reporting delays, Pacs Group is looking to gain operational momentum in 2026, the firm notes.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PACS
Unlock Now

Valuation Metrics

The current forward P/E ratio for Pacs Group Inc (PACS.N) is 6.31, compared to its 5-year average forward P/E of 11.79. For a more detailed relative valuation and DCF analysis to assess Pacs Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
11.79
Current PE
6.31
Overvalued PE
17.97
Undervalued PE
5.62

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
3.27
Current EV/EBITDA
-67.79
Overvalued EV/EBITDA
32.70
Undervalued EV/EBITDA
-26.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.77
Current PS
0.82
Overvalued PS
1.15
Undervalued PS
0.39

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

bullish stocks today
Intellectia · 35 candidates
Market Cap: >= 2.00BRsi Category: moderate, overboughtPrice Change Pct: >= $1.50Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
MASI logo
MASI
Masimo Corp
9.38B
ZIM logo
ZIM
ZIM Integrated Shipping Services Ltd
3.35B
KNF logo
KNF
Knife River Corp
5.32B
ENLT logo
ENLT
Enlight Renewable Energy Ltd
9.96B
NESR logo
NESR
National Energy Services Reunited Corp
2.44B
LU logo
LU
Lufax Holding Ltd
2.70B

Whales Holding PACS

C
Cohen & Steers Capital Management, Inc.
Holding
PACS
+2.66%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Pacs Group Inc (PACS) stock price today?

The current price of PACS is 31.67 USD — it has decreased -1.4

What is Pacs Group Inc (PACS)'s business?

PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services.

What is the price predicton of PACS Stock?

Wall Street analysts forecast PACS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PACS is42.60 USD with a low forecast of 40.00 USD and a high forecast of 47.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Pacs Group Inc (PACS)'s revenue for the last quarter?

Pacs Group Inc revenue for the last quarter amounts to 1.36B USD, increased 12.43

What is Pacs Group Inc (PACS)'s earnings per share (EPS) for the last quarter?

Pacs Group Inc. EPS for the last quarter amounts to 0.38 USD, increased 58.33

How many employees does Pacs Group Inc (PACS). have?

Pacs Group Inc (PACS) has 47455 emplpoyees as of April 02 2026.

What is Pacs Group Inc (PACS) market cap?

Today PACS has the market capitalization of 4.98B USD.